Zobrazeno 1 - 10
of 64
pro vyhledávání: '"M I Ruge"'
Autor:
Roland Goldbrunner, Heidrun Golla, Marc Schlamann, Cornelia Mauch, M. Herling, A. H. Scheel, Eren Celik, M. I. Ruge, Norbert Galldiks, Stefan Grau
Publikováno v:
Der Chirurg. 92:200-209
Die Inzidenz, Behandlung und Prognose von Patienten mit Hirnmetastasen haben sich in den letzten Jahrzehnten grundlegend geandert. Wahrend die Uberlebenszeit zerebral metastasierter Patienten noch vor 10 Jahren durchschnittlich 3 bis maximal 6 Monate
Autor:
R Gutsche, P Lohmann, M Hoevels, D Ruess, N Galldiks, V Visser-Vandewalle, H Treuer, M I Ruge, M Kocher
Publikováno v:
Neuro-Oncology. 24:ii1-ii2
Background Brain metastases show different patterns of contrast enhancement, potentially reflecting hypoxic and necrotic tumor regions with reduced radiosensitivity. An objective evaluation of these patterns might allow a prediction of response to ra
Autor:
G S Ceccon, J Werner, M I Ruge, R Goldbrunner, E Celik, C Baues, M Deckert, A Brunn, R Büttner, H Golla, L Nogova, M Schlamann, C Kabbasch, D Rueß, J Hampl, M Wollring, E K Bauer, C Tscherpel, G R Fink, K Langen, N Galldiks
Publikováno v:
Neuro-Oncology. 24:ii4-ii5
Background Following neurooncological treatment of brain tumors, neurooncologists are often confronted with equivocal MRI findings (e.g., treatment-related changes such as pseudoprogression, non-measurable contrast-enhancing lesions, T2/FLAIR signal
Autor:
M Friedrich, E Farrher, S Caspers, P Lohmann, G Stoffels, C Filss, C Weiss Lucas, M I Ruge, K J Langen, N J Shah, G R Fink, N Galldiks, M Kocher
Publikováno v:
Neuro-Oncology. 24:ii5-ii6
Background In glioma patients, multimodal therapy and recurrent tumor result in local brain tissue changes, characterized by pathologic findings in structural MRI and metabolic PET images. Little is known about these different lesion types’ impact
Autor:
Mauritius Hoevels, Christian Baues, Daniel Rueß, M. I. Ruge, Martin Kocher, Stefan Grau, Harald Treuer, Christina Hamisch, Lea Pöhlmann
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
Stereotactic radiosurgery (SRS) has evolved as widely accepted treatment option for small-sized (Koos I up to II) vestibular schwannoma (VS). For larger tumors (prevalent Koos VI), microsurgery or combined treatment strategies are mostly recommended.
Autor:
M Kocher, C Jockwitz, P Lohmann, G Stoffels, C Filss, F M Motthagy, M I Ruge, C Weiss Lucas, R Goldbrunner, N J Shah, G R Fink, N Galldiks, K Langen, S Caspers
Publikováno v:
Neuro-Oncology. 24:ii23-ii23
Background Cognitive deficits are common in glioma patients following multimodality therapy, but the relative impact of different types and locations of treatment-related brain damage and recurrent tumors on cognition is not well understood. Material
Publikováno v:
Neuro-Oncology. 24:ii65-ii65
Background To asses demographic and clinical parameters, treatment, and course of disease in patients surviving longer ≥ 5 years after the diagnosis of brain metastasis (BM). Material and Methods We retrospectively identified patients who were trea
Autor:
M Kocher, C Jockwitz, C Lerche, M Sabel, P Lohmann, G Stoffels, C Filss, F M Motthagy, M I Ruge, G R Fink, N J Shah, N Galldiks, S Caspers, K Langen
Publikováno v:
Neuro-Oncology. 24:ii23-ii23
Background Long-term survivors of whole brain radiation (WBRT) are at significant risk for developing cognitive deficits, but knowledge about the underlying pathophysiological mechanisms is limited. Therefore, we here report a rare case with a singul
Publikováno v:
best practice onkologie. 14:284-292
Meningeome und Vestibularisschwannome zahlen zu den gutartigen intrakraniellen Tumoren und gehen von den Hirnhauten bzw. den Hirnnerven aus. Die Inzidenz ist mit 4,1 bzw. 1 Neuerkrankung/100.000 Einwohner sehr niedrig, wobei die Anzahl mittels Magnet
Autor:
Christina Hamisch, Bogdana Suchorska, Harald Treuer, K. Mahnkopf, Juergen Voges, M. I. Ruge, Mininder S. Kocher, R. E. Lehrke
Publikováno v:
Journal of Neuro-Oncology. 130:123-131
The current study analyzed the outcome after stereotactic brachytherapy (SBT) using iodine-125 seeds in anaplastic astrocytoma, oligoastrocytoma or oligodendroglioma not suitable for resection. Out of 223 patients harbouring a malignant glioma treate